SIRT1 and chronic myelogenous leukemia, BCR-ABL1 positive: SIRT1 has been shown to act as a crucial promoter in the maintenance and self-renewal properties of cancer stem cells (e.g., glioma, colorectal, breast, pancreatic CSCs, CML, and AML SCs) [161,162,163,164,165].